In a major clinical trial, researchers have discovered that vaporized nicotine products, or VNPs, are significantly more ...

A new study from the University of British Columbia (UBC) has found that high insulin levels—commonly seen in people with ...

The Revell family hoped a gene therapy could buy time for their sons, who have a rare and fatal disease. After two patients died, the drug’s manufacturer halted dosing under pressure from the FDA.

VCU Massey Comprehensive Cancer Center is the first site in the United States to be activated in a global Phase 2a clinical ...

Experts are calling for tailored strategies to enhance the diagnosis, treatment, and monitoring of older people with multiple ...

There is an urgent need for more inclusive and community-focused cancer clinical trials, according to Kimberly (Cary) ...

Raleigh-based Focal Medical, an oncology device company that received early funding from the North Carolina Biotechnology Center, has been acquired by a Florida biopharmaceutical company. Financial ...

Unpredictable FDA and funding woes delay crucial drug approvals, depriving thousands of patients access to vital treatments ...

The trial will test several treatment approaches in the maintenance setting for extensive stage small cell lung cancer.

New Jersey-based drugmaker Bristol Myers Squibb this month dedicated its first production facility in Indiana, a former north ...

As life-extending technologies and aging interventions proliferate, questions surround who will be granted access to a longer ...

Mariam Eskander, MD, explores how food insecurity and geographic barriers hinder breast cancer trial participation, ...